ReviewBMC pediatrics2026
Chromosome 17q23.1-q23.2 deletion syndrome with severe pulmonary hypertension in neonates: two case reports and literature review.
Review in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rapid whole-genome sequencing in the pediatric intensive care unit: from etiologic diagnosis to precision management-a narrative review.Translational pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundChromosome 17q23.1-q23.2 deletion syndrome is a rare genetic disorder characterized by various congenital defects, including microcephaly, heart and lung defects, limb abnormalities, and mild-to-severe developmental delay. Respiratory distress and severe pulmonary hypertension (PH) are possible initial symptoms. CASE PRESENTATION: We report two cases of full-term neonates with respiratory distress presenting shortly after birth. They both presented with severe PH in the early postnatal period, with oxygenation indices exceeding 70. Their symptoms were temporarily relieved with comprehensive treatment but PH either persisted into, or reappeared in infancy. Case 1 had an anomalous origin of the right upper lobe bronchus on chest computed tomography (CT) imaging, while Case 2 had an atrial septal defect and cor triatriatum sinister on echocardiography. Case 2 also exhibited bilateral inner ear malformations and bilateral irregularities in the morphology of the auditory ossicles on temporal bone CT imaging. Whole-exome sequencing revealed a 2.0-2.3 Mb de novo heterozygous deletion at 17q23.1-q23.2 encompassing T-box transcription factor 2 and 4 genes in both infants, which were confirmed by quantitative real-time PCR. Despite receiving intensive care, they succumbed to irreversible PH and respiratory and heart failure, with one passing away at 3 months and the other at 20 months of age.
conclusionsThis is the first report of two cases of chromosome 17q23.1-q23.2 deletion syndrome diagnosed after birth in China, both associated with intractable PH, expanding the current clinical phenotype spectrum of this disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.